Updated: 12/31/2020 — You can also download a pdf or the original .docx
In its public medical education role, The Preventive Medicine Center (PMC) concludes that these corona virus treatments for which there is validation would be helpful for those who need it and/or who await a vaccine. If practitioners used these already available treatment options which can be thoughtfully combined, the corona virus infection might simply be reduced to just a bad cold and rarely anything more. As this information may not be widely known, it is summarized here to help patients engage in a discussion with their health care providers.
– Decadron/also known as dexamethasone (or equivalent dose of prednisone: steroids similar to the natural stress hormone hydrocortisone produced by the adrenal glands)
– Regeneron 2 IgG antibodies for outpatients given by IV for age above 17, given within 72 hours of a positive test, within 7 days of symptom onset
– Remdesivir (an intravenous viral nucleotide analogue for in-hospital use that inhibits viral RNA polymerases thereby reducing viral replication): especially effective when combined with other agents, e.g. baricitinib
– Certain asthma inhibitors (Asmanex/ciclesonide inhaler or steroid similars, Singulair/montelukast to reduce lung inflammation)
– Stomach acid & cold/viral reducers (Pepcid/famotidine, Halodine/Povidone-Iodine Nasal Antiseptic Liquid Packet)
– Hydroxychloroquine + azithromycin + zinc as antibiotic and corona virus”ionophore” now considered acceptable by the AMA
– Colchicine (anti-inflammatory gout medicine to calm general inflammation)
– Ivermectin (lice treatment inhibits host proteins which allow importing the virus and also reduce viral-induced nitric oxide and prostaglandin E2 via MAPK inhibition)
– Metformin (diabetes medicine found to be effective in women)
– Bystolic (beta blocker that reduces platelet aggregation-reducing clotting and “calms” the heart that may be under attack)
– Livalo (statins reduce mortality by 25%)
– Tricor (a triglyceride-blood fat treatment)
– Persantin/dipyridamole anti-clotting pill
– Aspirin (low dose anti-platelet agents to inhibit clotting)
– Luvox/fluvoxamine (an anti-depressant that is an S1R agonist thereby affecting the corona virus)
– Iloprost (investigational lung blood vessel dilator that results in 79% lower risk of developing severe disease)
An in-depth Summary Corona Virus Update is available at the PMC website www.thepmc.org. The PMC is an IRS recognized 501(c)(3) nonprofit educational organization that is dedicated to promoting a realistic and supportive approach to health: achieving disease prevention and reversal where possible through a combination of innovative and traditional medical science.